{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:38:18Z","timestamp":1792787898162,"version":"4.5.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T00:00:00Z","timestamp":1783900800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:00:00Z","timestamp":1791331200000},"content-version":"vor","delay-in-days":86,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"National Natural Science Foundation of China","award":["82370267"],"award-info":[{"award-number":["82370267"]}],"id":[{"id":"https:\/\/ror.org\/01h0zpd94","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Noncommunicable Chronic Diseases-National Science and Technology Major Project","award":["2024ZD0531701"],"award-info":[{"award-number":["2024ZD0531701"]}]},{"name":"Project of Heart Failure Database of Nanjing Drum Tower Hospital","award":["2024-LCYJ-DBZ-03"],"award-info":[{"award-number":["2024-LCYJ-DBZ-03"]}],"id":[{"id":"https:\/\/ror.org\/026axqv54","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"DOI":"10.1186\/s12872-026-06241-6","type":"journal-article","created":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T07:25:18Z","timestamp":1783927518000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Prognostic value of C-reactive protein\u2013triglyceride\u2013glucose index in hospitalised patients with acute decompensated heart failure"],"prefix":"10.1186","volume":"26","author":[{"given":"Wei","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miaoxin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaming","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingyi","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,13]]},"reference":[{"issue":"48","key":"6241_CR1","doi-asserted-by":"publisher","first-page":"4901","DOI":"10.1093\/eurheartj\/ehab670","volume":"42","author":"TA McDonagh","year":"2021","unstructured":"McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, B\u00f6hm M, Burri H, Butler J, \u010celutkien\u0117 J, Chioncel O, et al. Corrigendum to: 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) With the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2021;42(48):4901.","journal-title":"Eur Heart J"},{"issue":"1","key":"6241_CR2","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s40364-025-00728-8","volume":"13","author":"J Ran","year":"2025","unstructured":"Ran J, Zhou P, Wang J, Zhao X, Huang Y, Zhou Q, Zhai M, Zhang Y. Global, regional, and national burden of heart failure and its underlying causes, 1990\u20132021: results from the global burden of disease study 2021. Biomark Res. 2025;13(1):16.","journal-title":"Biomark Res"},{"issue":"18","key":"6241_CR3","first-page":"e876","volume":"145","author":"PA Heidenreich","year":"2022","unstructured":"Heidenreich PA, Bozkurt B, Aguilar D, Allen LA, Byun JJ, Colvin MM, Deswal A, Drazner MH, Dunlay SM, Evers LR, et al. 2022 AHA\/ACC\/HFSA Guideline for the Management of Heart Failure: Executive Summary: A Report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2022;145(18):e876\u201394.","journal-title":"Circulation"},{"issue":"6","key":"6241_CR4","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1093\/cvr\/cvad026","volume":"119","author":"Corrigendum to","year":"2023","unstructured":"Corrigendum to. Global burden of heart failure: a comprehensive and updated review of epidemiology. Cardiovasc Res. 2023;119(6):1453.","journal-title":"Cardiovasc Res"},{"key":"6241_CR5","doi-asserted-by":"publisher","first-page":"e11","DOI":"10.15420\/cfr.2023.05","volume":"9","author":"B Shahim","year":"2023","unstructured":"Shahim B, Kapelios CJ, Savarese G, Lund LH. Global Public Health Burden of Heart Failure: An Updated Review. Card Fail Rev. 2023;9:e11.","journal-title":"Card Fail Rev"},{"key":"6241_CR6","doi-asserted-by":"publisher","first-page":"650278","DOI":"10.3389\/fcvm.2021.650278","volume":"8","author":"Z Li","year":"2021","unstructured":"Li Z, Zhao H, Wang J. Metabolism and Chronic Inflammation: The Links Between Chronic Heart Failure and Comorbidities. Front Cardiovasc Med. 2021;8:650278.","journal-title":"Front Cardiovasc Med"},{"issue":"5","key":"6241_CR7","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/j.jchf.2014.04.008","volume":"2","author":"K Rahimi","year":"2014","unstructured":"Rahimi K, Bennett D, Conrad N, Williams TM, Basu J, Dwight J, Woodward M, Patel A, McMurray J, MacMahon S. Risk prediction in patients with heart failure: a systematic review and analysis. JACC Heart Fail. 2014;2(5):440\u20136.","journal-title":"JACC Heart Fail"},{"issue":"10","key":"6241_CR8","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1161\/CIRCULATIONAHA.104.508465","volume":"112","author":"IS Anand","year":"2005","unstructured":"Anand IS, Latini R, Florea VG, Kuskowski MA, Rector T, Masson S, Signorini S, Mocarelli P, Hester A, Glazer R, et al. C-reactive protein in heart failure: prognostic value and the effect of valsartan. Circulation. 2005;112(10):1428\u201334.","journal-title":"Circulation"},{"key":"6241_CR9","doi-asserted-by":"crossref","unstructured":"Caturano A, Galiero R, Vetrano E, Sardu C, Rinaldi L, Russo V, Monda M, Marfella R, Sasso FC. Insulin-Heart Axis: Bridging Physiology to Insulin Resistance. Int J Mol Sci 2024, 25(15):8369.","DOI":"10.3390\/ijms25158369"},{"issue":"5","key":"6241_CR10","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1590\/S0066-782X2007000500014","volume":"88","author":"H Villacorta","year":"2007","unstructured":"Villacorta H, Masetto AC, Mesquita ET. C-reactive protein: an inflammatory marker with prognostic value in patients with decompensated heart failure. Arq Bras Cardiol. 2007;88(5):585\u20139.","journal-title":"Arq Bras Cardiol"},{"key":"6241_CR11","doi-asserted-by":"crossref","unstructured":"Nishimoto Y, Kato T, Morimoto T, Yaku H, Inuzuka Y, Tamaki Y, Yamamoto E, Yoshikawa Y, Kitai T, Taniguchi R et al. C-reactive protein at discharge and 1-year mortality in hospitalised patients with acute decompensated heart failure: an observational study. BMJ Open 2020, 10(12):e041068.","DOI":"10.1136\/bmjopen-2020-041068"},{"issue":"1","key":"6241_CR12","doi-asserted-by":"publisher","first-page":"21672","DOI":"10.1038\/s41598-024-72137-0","volume":"14","author":"E Santas","year":"2024","unstructured":"Santas E, Villar S, Palau P, Ll\u00e0cer P, de la Espriella R, Mi\u00f1ana G, Lorenzo M, N\u00fa\u00f1ez-Mar\u00edn G, G\u00f3rriz JL, Carratal\u00e1 A, et al. High-sensitivity C-reactive protein and risk of clinical outcomes in patients with acute heart failure. Sci Rep. 2024;14(1):21672.","journal-title":"Sci Rep"},{"issue":"3","key":"6241_CR13","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.amjcard.2010.09.039","volume":"107","author":"S Uthamalingam","year":"2011","unstructured":"Uthamalingam S, Patvardhan EA, Subramanian S, Ahmed W, Martin W, Daley M, Capodilupo R. Utility of the neutrophil to lymphocyte ratio in predicting long-term outcomes in acute decompensated heart failure. Am J Cardiol. 2011;107(3):433\u20138.","journal-title":"Am J Cardiol"},{"key":"6241_CR14","doi-asserted-by":"crossref","unstructured":"Cho JH, Cho HJ, Lee HY, Ki YJ, Jeon ES, Hwang KK, Chae SC, Baek SH, Kang SM, Choi DJ et al. Neutrophil-lymphocyte ratio in patients with acute heart failure predicts in-hospital and long-term mortality. J Clin Med 2020, 9(2):557.","DOI":"10.3390\/jcm9020557"},{"key":"6241_CR15","doi-asserted-by":"publisher","first-page":"1005697","DOI":"10.3389\/fimmu.2022.1005697","volume":"13","author":"X Zhu","year":"2022","unstructured":"Zhu X, Cheang I, Xu F, Gao R, Liao S, Yao W, Zhou Y, Zhang H, Li X. Long-term prognostic value of inflammatory biomarkers for patients with acute heart failure: Construction of an inflammatory prognostic scoring system. Front Immunol. 2022;13:1005697.","journal-title":"Front Immunol"},{"issue":"1","key":"6241_CR16","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1186\/s12933-022-01546-0","volume":"21","author":"X Liu","year":"2022","unstructured":"Liu X, Tan Z, Huang Y, Zhao H, Liu M, Yu P, Ma J, Zhao Y, Zhu W, Wang J. Relationship between the triglyceride-glucose index and risk of cardiovascular diseases and mortality in the general population: a systematic review and meta-analysis. Cardiovasc Diabetol. 2022;21(1):124.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"6241_CR17","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1186\/s12933-022-01658-7","volume":"21","author":"X Li","year":"2022","unstructured":"Li X, Chan JSK, Guan B, Peng S, Wu X, Lu X, Zhou J, Hui JMH, Lee YHA, Satti DI, et al. Triglyceride-glucose index and the risk of heart failure: Evidence from two large cohorts and a mendelian randomization analysis. Cardiovasc Diabetol. 2022;21(1):229.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"6241_CR18","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/s12933-022-01507-7","volume":"21","author":"R Huang","year":"2022","unstructured":"Huang R, Wang Z, Chen J, Bao X, Xu N, Guo S, Gu R, Wang W, Wei Z, Wang L. Prognostic value of triglyceride glucose (TyG) index in patients with acute decompensated heart failure. Cardiovasc Diabetol. 2022;21(1):88.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"6241_CR19","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1186\/s12933-025-02686-9","volume":"24","author":"G Huo","year":"2025","unstructured":"Huo G, Tang Y, Liu Z, Cao J, Yao Z, Zhou D. Association between C-reactive protein-triglyceride glucose index and stroke risk in different glycemic status: insights from the China Health and Retirement Longitudinal Study (CHARLS). Cardiovasc Diabetol. 2025;24(1):142.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"6241_CR20","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1186\/s12933-025-02848-9","volume":"24","author":"H Ou","year":"2025","unstructured":"Ou H, Wei M, Li X, Xia X. C-reactive protein-triglyceride glucose index in evaluating cardiovascular disease and All-cause mortality incidence among individuals across stages 0\u20133 of cardiovascular-kidney-metabolic syndrome: a nationwide prospective cohort study. Cardiovasc Diabetol. 2025;24(1):296.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"6241_CR21","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1186\/s12933-025-02835-0","volume":"24","author":"Y Sun","year":"2025","unstructured":"Sun Y, Guo Y, Ma S, Mao Z, Meng D, Xuan K, Lu R, Pan X, Zhu X. Association of C-reactive protein-triglyceride glucose index with the incidence and mortality of cardiovascular disease: a retrospective cohort study. Cardiovasc Diabetol. 2025;24(1):313.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"6241_CR22","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1186\/s12933-025-02876-5","volume":"24","author":"Y Chen","year":"2025","unstructured":"Chen Y, Jia W, Guo J, Yang H, Sheng X, Wei L, Li J. Association between the C-reactive protein-triglyceride glucose index and new-onset coronary heart disease among metabolically heterogeneous individuals. Cardiovasc Diabetol. 2025;24(1):316.","journal-title":"Cardiovasc Diabetol"},{"key":"6241_CR23","doi-asserted-by":"publisher","first-page":"905266","DOI":"10.3389\/fendo.2022.905266","volume":"13","author":"GT Ruan","year":"2022","unstructured":"Ruan GT, Xie HL, Zhang HY, Liu CA, Ge YZ, Zhang Q, Wang ZW, Zhang X, Tang M, Song MM, et al. A Novel Inflammation and Insulin Resistance Related Indicator to Predict the Survival of Patients With Cancer. Front Endocrinol (Lausanne). 2022;13:905266.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"6241_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jchf.2017.07.012","volume":"6","author":"WJ Paulus","year":"2018","unstructured":"Paulus WJ, Dal Canto E. Distinct Myocardial Targets for Diabetes Therapy in Heart Failure With Preserved or Reduced Ejection Fraction. JACC Heart Fail. 2018;6(1):1\u20137.","journal-title":"JACC Heart Fail"},{"issue":"2","key":"6241_CR25","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1161\/CIRCHEARTFAILURE.112.972828","volume":"6","author":"JE Ho","year":"2013","unstructured":"Ho JE, Lyass A, Lee DS, Vasan RS, Kannel WB, Larson MG, Levy D. Predictors of new-onset heart failure: differences in preserved versus reduced ejection fraction. Circ Heart Fail. 2013;6(2):279\u201386.","journal-title":"Circ Heart Fail"},{"issue":"9","key":"6241_CR26","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1002\/ejhf.1182","volume":"20","author":"G Savarese","year":"2018","unstructured":"Savarese G, Carrero JJ, Pitt B, Anker SD, Rosano GMC, Dahlstr\u00f6m U, Lund LH. Factors associated with underuse of mineralocorticoid receptor antagonists in heart failure with reduced ejection fraction: an analysis of 11 215 patients from the Swedish Heart Failure Registry. Eur J Heart Fail. 2018;20(9):1326\u201334.","journal-title":"Eur J Heart Fail"},{"issue":"4","key":"6241_CR27","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1002\/ejhf.1320","volume":"21","author":"A van der Pol","year":"2019","unstructured":"van der Pol A, van Gilst WH, Voors AA, van der Meer P. Treating oxidative stress in heart failure: past, present and future. Eur J Heart Fail. 2019;21(4):425\u201335.","journal-title":"Eur J Heart Fail"},{"issue":"20","key":"6241_CR28","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1056\/NEJMoa021993","volume":"347","author":"PM Ridker","year":"2002","unstructured":"Ridker PM, Rifai N, Rose L, Buring JE, Cook NR. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med. 2002;347(20):1557\u201365.","journal-title":"N Engl J Med"},{"key":"6241_CR29","doi-asserted-by":"publisher","first-page":"1163900","DOI":"10.3389\/fcvm.2023.1163900","volume":"10","author":"J Xiu","year":"2023","unstructured":"Xiu J, Lin X, Chen Q, Yu P, Lu J, Yang Y, Chen W, Bao K, Wang J, Zhu J, et al. The aggregate index of systemic inflammation (AISI): a novel predictor for hypertension. Front Cardiovasc Med. 2023;10:1163900.","journal-title":"Front Cardiovasc Med"},{"issue":"19","key":"6241_CR30","doi-asserted-by":"publisher","first-page":"e029386","DOI":"10.1161\/JAHA.123.029386","volume":"12","author":"L Zhang","year":"2023","unstructured":"Zhang L, He G, Huo X, Tian A, Ji R, Pu B, Peng Y. Long-Term Cumulative High-Sensitivity C-Reactive Protein and Mortality Among Patients With Acute Heart Failure. J Am Heart Assoc. 2023;12(19):e029386.","journal-title":"J Am Heart Assoc"},{"key":"6241_CR31","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.amjcard.2022.06.037","volume":"180","author":"BA Davison","year":"2022","unstructured":"Davison BA, Takagi K, Edwards C, Adams KF, Butler J, Collins SP, Dorobantu MI, Ezekowitz JA, Filippatos G, Greenberg BH, et al. Neutrophil-to-Lymphocyte Ratio and Outcomes in Patients Admitted for Acute Heart Failure (As Seen in the BLAST-AHF, Pre-RELAX-AHF, and RELAX-AHF Studies). Am J Cardiol. 2022;180:72\u201380.","journal-title":"Am J Cardiol"},{"issue":"5","key":"6241_CR32","doi-asserted-by":"publisher","first-page":"e13230","DOI":"10.1111\/eci.13230","volume":"50","author":"YL Yang","year":"2020","unstructured":"Yang YL, Wu CH, Hsu PF, Chen SC, Huang SS, Chan WL, Lin SJ, Chou CY, Chen JW, Pan JP, et al. Systemic immune-inflammation index (SII) predicted clinical outcome in patients with coronary artery disease. Eur J Clin Invest. 2020;50(5):e13230.","journal-title":"Eur J Clin Invest"},{"issue":"1","key":"6241_CR33","doi-asserted-by":"publisher","first-page":"18282","DOI":"10.1038\/s41598-025-01196-8","volume":"15","author":"X Bai","year":"2025","unstructured":"Bai X, Cheng L, Wang H, Deng Y, Tong X, Wen W, Liu X, Zhou J, Yuan Z. The aggregate index of systemic inflammation (AISI) and the risk of All-cause, cardiovascular, and cardio-cerebrovascular mortality in congestive heart failure patients: results from NHANES 1999\u20132018. Sci Rep. 2025;15(1):18282.","journal-title":"Sci Rep"},{"issue":"1","key":"6241_CR34","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1186\/s12933-023-01973-7","volume":"22","author":"A Khalaji","year":"2023","unstructured":"Khalaji A, Behnoush AH, Khanmohammadi S, Ghanbari Mardasi K, Sharifkashani S, Sahebkar A, Vinciguerra C, Cannavo A. Triglyceride-glucose index and heart failure: a systematic review and meta-analysis. Cardiovasc Diabetol. 2023;22(1):244.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"6241_CR35","doi-asserted-by":"publisher","first-page":"16157","DOI":"10.1038\/s41598-025-00129-9","volume":"15","author":"J Xiao","year":"2025","unstructured":"Xiao J, Li Y, Gao X, Yan B, Chen F, Zhang C, Wang C, Han T, Zhang Y. Association between triglyceride-glucose index and all cause mortality in critically ill patients with heart failure. Sci Rep. 2025;15(1):16157.","journal-title":"Sci Rep"},{"issue":"1","key":"6241_CR36","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s12933-023-02115-9","volume":"23","author":"K Dang","year":"2024","unstructured":"Dang K, Wang X, Hu J, Zhang Y, Cheng L, Qi X, Liu L, Ming Z, Tao X, Li Y. The association between triglyceride-glucose index and its combination with obesity indicators and cardiovascular disease: NHANES 2003\u20132018. Cardiovasc Diabetol. 2024;23(1):8.","journal-title":"Cardiovasc Diabetol"},{"key":"6241_CR37","first-page":"101135","volume":"49","author":"G He","year":"2024","unstructured":"He G, Zhang Z, Wang C, Wang W, Bai X, He L, Chen S, Li G, Yang Y, Zhang X, et al. Association of the triglyceride-glucose index with All-cause and cause-specific mortality: a population-based cohort study of 3.5 million adults in China. Lancet Reg Health West Pac. 2024;49:101135.","journal-title":"Lancet Reg Health West Pac"},{"key":"6241_CR38","doi-asserted-by":"publisher","first-page":"1688566","DOI":"10.3389\/fnut.2025.1688566","volume":"12","author":"Y Shi","year":"2025","unstructured":"Shi Y, Gao C, Xu Y, Yuan F. Association between triglyceride glucose-body mass index and long-term adverse outcomes in individuals with heart failure: a retrospective cohort study. Front Nutr. 2025;12:1688566.","journal-title":"Front Nutr"},{"issue":"6","key":"6241_CR39","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1002\/dmrr.634","volume":"22","author":"E Cersosimo","year":"2006","unstructured":"Cersosimo E, DeFronzo RA. Insulin resistance and endothelial dysfunction: the road map to cardiovascular diseases. Diabetes Metab Res Rev. 2006;22(6):423\u201336.","journal-title":"Diabetes Metab Res Rev"},{"issue":"1","key":"6241_CR40","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1093\/eurheartj\/ehad613","volume":"45","author":"to Correction","year":"2024","unstructured":"Correction to. 2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) With the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2024;45(1):53.","journal-title":"Eur Heart J"},{"issue":"1","key":"6241_CR41","doi-asserted-by":"publisher","first-page":"7","DOI":"10.15420\/cfr.2016:25:2","volume":"3","author":"G Savarese","year":"2017","unstructured":"Savarese G, Lund LH. Global Public Health Burden of Heart Failure. Card Fail Rev. 2017;3(1):7\u201311.","journal-title":"Card Fail Rev"},{"issue":"11","key":"6241_CR42","doi-asserted-by":"publisher","first-page":"104127","DOI":"10.1016\/j.numecd.2025.104127","volume":"35","author":"Y Chang","year":"2025","unstructured":"Chang Y, Park JY, Song TJ. Association between the triglyceride-glucose index and the incidence risk of heart failure: A nationwide cohort study. Nutr Metab Cardiovasc Dis. 2025;35(11):104127.","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"1","key":"6241_CR43","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1186\/s12933-025-02869-4","volume":"24","author":"X Ma","year":"2025","unstructured":"Ma X, Ma X, Wang Y, Qiu G, Zhang C. Associations of cumulative exposure and dynamic trajectories of the C-reactive protein-triglyceride-glucose index with incident cardiovascular disease in middle-aged and older Chinese adults: a nationwide cohort study. Cardiovasc Diabetol. 2025;24(1):303.","journal-title":"Cardiovasc Diabetol"},{"key":"6241_CR44","doi-asserted-by":"publisher","first-page":"1627821","DOI":"10.3389\/fendo.2025.1627821","volume":"16","author":"L Hu","year":"2025","unstructured":"Hu L, Deng Y, Liu C, Kuang Y, Huang X, Zhang J, Huang W, Jian Y, Xie G, Zou Y, et al. Aggregate index of systemic inflammation as a novel prognostic biomarker in Chinese patients with acute decompensated heart failure: a population-based real-world study. Front Endocrinol (Lausanne). 2025;16:1627821.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"12","key":"6241_CR45","doi-asserted-by":"publisher","first-page":"e0335916","DOI":"10.1371\/journal.pone.0335916","volume":"20","author":"X Xu","year":"2025","unstructured":"Xu X, Liu J, Sun Y, Sun P, Yu X. The association between the C-reactive protein-triglyceride-glucose index and cardiovascular diseases: A cohort study using data from the China Health and Retirement Longitudinal Study 2011\u20132020. PLoS ONE. 2025;20(12):e0335916.","journal-title":"PLoS ONE"},{"issue":"1","key":"6241_CR46","doi-asserted-by":"publisher","first-page":"24687","DOI":"10.1038\/s41598-025-10184-x","volume":"15","author":"N Tang","year":"2025","unstructured":"Tang N, Chen X, Li H, Cheng S, Hu Y, Wang L, Zhou Q, Zhang Q, Hao J, Qi C. Association of C reactive protein triglyceride glucose index with mortality in coronary heart disease and type 2 diabetes from NHANES data. Sci Rep. 2025;15(1):24687.","journal-title":"Sci Rep"},{"issue":"5","key":"6241_CR47","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.jchf.2020.12.015","volume":"9","author":"J Tromp","year":"2021","unstructured":"Tromp J, Ouwerkerk W, Cleland JGF, Angermann CE, Dahlstrom U, Tiew-Hwa Teng K, Bamadhaj S, Ertl G, Hassanein M, Perrone SV, et al. Global Differences in Burden and Treatment of Ischemic Heart Disease in Acute Heart Failure: REPORT-HF. JACC Heart Fail. 2021;9(5):349\u201359.","journal-title":"JACC Heart Fail"},{"issue":"4","key":"6241_CR48","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/j.hfc.2012.06.005","volume":"8","author":"AR Aroor","year":"2012","unstructured":"Aroor AR, Mandavia CH, Sowers JR. Insulin resistance and heart failure: molecular mechanisms. Heart Fail Clin. 2012;8(4):609\u201317.","journal-title":"Heart Fail Clin"},{"issue":"1","key":"6241_CR49","doi-asserted-by":"publisher","first-page":"2584308","DOI":"10.1080\/07853890.2025.2584308","volume":"57","author":"L Hou","year":"2025","unstructured":"Hou L, Li Y, Liu Q. C-reactive protein-triglyceride glucose index in predicting three-vessel coronary artery disease risk: a retrospective study using machine learning approaches. Ann Med. 2025;57(1):2584308.","journal-title":"Ann Med"},{"issue":"1","key":"6241_CR50","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1186\/s12872-025-05143-3","volume":"25","author":"Y Xu","year":"2025","unstructured":"Xu Y, Chen S, Zhu J, Wang Q, Li W, Pan G, Lv T, Huang Y, Qu W. C-reactive protein-triglyceride glucose index and stroke risk in early cardiovascular-kidney-metabolic syndrome: a National cohort study. BMC Cardiovasc Disord. 2025;25(1):634.","journal-title":"BMC Cardiovasc Disord"},{"issue":"8","key":"6241_CR51","first-page":"535","volume":"9","author":"M Packer","year":"2021","unstructured":"Packer M. Differential Pathophysiological Mechanisms in Heart Failure With a Reduced or Preserved Ejection Fraction in Diabetes. JACC: Heart Fail. 2021;9(8):535\u201349.","journal-title":"JACC: Heart Fail"},{"issue":"21","key":"6241_CR52","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1056\/NEJMoa1911303","volume":"381","author":"JJV McMurray","year":"2019","unstructured":"McMurray JJV, Solomon SD, Inzucchi SE, K\u00f8ber L, Kosiborod MN, Martinez FA, Ponikowski P, Sabatine MS, Anand IS, B\u011blohl\u00e1vek J, et al. Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction. N Engl J Med. 2019;381(21):1995\u20132008.","journal-title":"N Engl J Med"},{"issue":"15","key":"6241_CR53","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1056\/NEJMoa2022190","volume":"383","author":"M Packer","year":"2020","unstructured":"Packer M, Anker SD, Butler J, Filippatos G, Pocock SJ, Carson P, Januzzi J, Verma S, Tsutsui H, Brueckmann M, et al. Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure. N Engl J Med. 2020;383(15):1413\u201324.","journal-title":"N Engl J Med"},{"key":"6241_CR54","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.jclinepi.2015.04.005","volume":"69","author":"EW Steyerberg","year":"2016","unstructured":"Steyerberg EW, Harrell FE Jr. Prediction models need appropriate internal, internal-external, and external validation. J Clin Epidemiol. 2016;69:245\u20137.","journal-title":"J Clin Epidemiol"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12872-026-06241-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-026-06241-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-026-06241-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:30:43Z","timestamp":1791333043000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12872-026-06241-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,13]]},"references-count":54,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["6241"],"URL":"https:\/\/doi.org\/10.1186\/s12872-026-06241-6","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,13]]},"assertion":[{"value":"1 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study protocol was approved by the Medical Ethics Committee of Nanjing Drum Tower Hospital, Affiliated Hospital of Nanjing University Medical School (Approval No. 2021\u2013532-02). The requirement for informed consent was waived by the ethics committee owing to the retrospective study design. All patient data were de-identified before analysis.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"884"}}